Matrix rigidity regulates cancer cell growth by modulating cellular metabolism and protein synthesis

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Tilghman, Robert W ^a   Blais, Edik M ^b   Cowan, Catharine R ^a   Sherman, Nicholas E ^a   Grigera, Pablo R ^a   Jeffery, Erin D ^a   Fox, Jay W ^a   Blackman, Brett R ^b   Tschumperlin, Daniel J ^c   Papin, Jason A ^b   Parsons, J Thomas ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b University of Virginia   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIN D1; TUBULIN; ACRYLIC ACID RESIN; ADENOSINE TRIPHOSPHATE; BROXURIDINE; POLYACRYLAMIDE GELS;

ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; GLYCOLYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEOMICS; BIOMECHANICS; CHEMISTRY; EXTRACELLULAR MATRIX; ISOTOPE LABELING; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ACRYLIC RESINS; ADENOSINE TRIPHOSPHATE; BIOMECHANICS; BROMODEOXYURIDINE; CELL LINE, TUMOR; CELLULAR MICROENVIRONMENT; CYCLIN D1; EXTRACELLULAR MATRIX; HUMANS; ISOTOPE LABELING; MASS SPECTROMETRY; NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEOMICS;

EID: 84862068212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037231     Document Type: Article

References (41)

1. Friedl P, Alexander S, (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147: 992-1009.
2. Paez D, Labonte MJ, Bohanes P, Zhang W, Benhanim L, et al. (2012) Cancer dormancy: a model of early dissemination and late cancer recurrence. Clinical Cancer Research 18: 645-653.
3. Huang S, Ingber DE, (2005) Cell tension, matrix mechanics, and cancer development. Cancer Cell 8: 175-176.
4. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, et al. (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891-906.
5. Tilghman RW, Cowan CR, Mih JD, Koryakina Y, Gioeli D, et al. (2010) Matrix rigidity regulates cancer cell growth and cellular phenotype. PLoS One 5: e12905.
6. Mih JD, Sharif AS, Liu F, Marinkovic A, Symer MM, et al. (2011) A multiwell platform for studying stiffness-dependent cell biology. PLoS ONE 6: e19929.
7. Leight JL, Wozniak MA, Chen S, Lynch ML, Chen CS, (2012) Matrix rigidity regulates a switch between TGF-beta1-induced apoptosis and epithelial-mesenchymal transition. Mol Biol Cell 23: 781-791.
8. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, et al. (2010) Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer research 70: 5706-5716.
9. Barkan D, Green JE, Chambers AF, (2010) Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. European Journal of Cancer 46: 1181-1188.
10. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
11. Sherr CJ, Roberts JM, (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Development 9: 1149-1163.
12. Klein EA, Yin L, Kothapalli D, Castagnino P, Byfield FJ, et al. (2009) Cell-cycle control by physiological matrix elasticity and in vivo tissue stiffening. Current Biology: CB 19: 1511-1518.
13. Terry NH, White RA, (2006) Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo. Nat Protoc 1: 859-869.
14. Kostic A, Lynch CD, Sheetz MP, (2009) Differential matrix rigidity response in breast cancer cell lines correlates with the tissue tropism. PloS ONE 4: e6361.
15. Aguirre-Ghiso JA, (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7: 834-846.
16. Goss PE, Chambers AF, (2010) Does tumour dormancy offer a therapeutic target? Nature reviews Cancer 10: 871-877.
17. Schardt JA, Meyer M, Hartmann CH, Schubert F, Schmidt-Kittler O, et al. (2005) Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 8: 227-239.
18. Uhr JW, Pantel K, (2011) Controversies in clinical cancer dormancy. Proc Natl Acad Sci USA 108: 12396-12400.
19. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, et al. (2010) Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res 70: 5706-5716.
20. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, et al. (2008) Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68: 6241-6250.
21. Kleinman HK, Martin GR, (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15: 378-386.
22. Hughes CS, Postovit LM, Lajoie GA, (2010) Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10: 1886-1890.
23. Soofi SS, Last JA, Liliensiek SJ, Nealey PF, Murphy CJ, (2009) The elastic modulus of Matrigel as determined by atomic force microscopy. J Struct Biol 167: 216-219.
24. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, et al. (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241-254.
25. Schrader J, Gordon-Walker TT, Aucott RL, van Deemter M, Quaas A, et al. (2011) Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology 53: 1192-1205.
26. Sunyer R, Trepat X, Fredberg JJ, Farre R, Navajas D, (2009) The temperature dependence of cell mechanics measured by atomic force microscopy. Phys Biol 6: 025009.
27. Butcher DT, Alliston T, Weaver VM, (2009) A tense situation: forcing tumour progression. Nature Reviews Cancer 9: 108-122.
28. Rabinowitz JD, White E, (2010) Autophagy and metabolism. Science 330: 1344-1348.
29. Benecke BJ, Ben-Ze'ev A, Penman S, (1978) The control of mRNA production, translation and turnover in suspended and reattached anchorage-dependent fibroblasts. Cell 14: 931-939.
30. Farmer SR, Ben-Ze'av A, Benecke BJ, Penman S, (1978) Altered translatability of messenger RNA from suspended anchorage-dependent fibroblasts: reversal upon cell attachment to a surface. Cell 15: 627-637.
31. Ben-Ze'ev A, Farmer SR, Penman S, (1980) Protein synthesis requires cell-surface contact while nuclear events respond to cell shape in anchorage-dependent fibroblasts. Cell 21: 365-372.
32. Van Schaftingen E, Jett MF, Hue L, Hers HG, (1981) Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci USA 78: 3483-3486.
33. Moon JS, Kim HE, Koh E, Park SH, Jin WJ, et al. (2011) Kruppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer. J Biol Chem 286: 23808-23816.
34. Gehnrich SC, Gekakis N, Sul HS, (1988) Liver (B-type) phosphofructokinase mRNA. Cloning, structure, and expression. J Biol Chem 263: 11755-11759.
35. Dunaway GA, Leung GL, Thrasher JR, Cooper MD, (1978) Turnover of hepatic phosphofructokinase in normal and diabetic rats. Role of insulin and peptide stabilizing factor. J Biol Chem 253: 7460-7463.
36. Penning TM, Drury JE, (2007) Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms. Archives of Biochemistry and Biophysics 464: 241-250.
37. Szatrowski TP, Nathan CF, (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798.
38. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, et al. (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10: 241-252.
39. Rongvaux A, Andris F, Van Gool F, Leo O, (2003) Reconstructing eukaryotic NAD metabolism. Bioessays 25: 683-690.
40. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, et al. (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475: 231-234.
41. Grigera PR, Ma L, Borgman CA, Pinto AF, Sherman NE, et al. (2012) Mass spectrometric analysis identifies a cortactin-RCC2/TD60 interaction in mitotic cells. J Proteomics 75: 2153-2159.